ATE203530T1 - Adamantyl substituierte oxindole als pharmazeutische wirkstoffe - Google Patents

Adamantyl substituierte oxindole als pharmazeutische wirkstoffe

Info

Publication number
ATE203530T1
ATE203530T1 AT97303343T AT97303343T ATE203530T1 AT E203530 T1 ATE203530 T1 AT E203530T1 AT 97303343 T AT97303343 T AT 97303343T AT 97303343 T AT97303343 T AT 97303343T AT E203530 T1 ATE203530 T1 AT E203530T1
Authority
AT
Austria
Prior art keywords
active ingredients
pharmaceutical active
adamantyl substituted
substituted oxindoles
oxindoles
Prior art date
Application number
AT97303343T
Other languages
English (en)
Inventor
Joseph Peter Lyssikatos
Robert Alfred Volkmann
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of ATE203530T1 publication Critical patent/ATE203530T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT97303343T 1996-05-28 1997-05-16 Adamantyl substituierte oxindole als pharmazeutische wirkstoffe ATE203530T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1849096P 1996-05-28 1996-05-28

Publications (1)

Publication Number Publication Date
ATE203530T1 true ATE203530T1 (de) 2001-08-15

Family

ID=21788193

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97303343T ATE203530T1 (de) 1996-05-28 1997-05-16 Adamantyl substituierte oxindole als pharmazeutische wirkstoffe

Country Status (9)

Country Link
EP (1) EP0810223B1 (de)
JP (1) JP3161994B2 (de)
AT (1) ATE203530T1 (de)
CA (1) CA2206104C (de)
DE (1) DE69705772T2 (de)
DK (1) DK0810223T3 (de)
ES (1) ES2159087T3 (de)
GR (1) GR3036968T3 (de)
PT (1) PT810223E (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1230100A (en) * 1998-10-29 2000-05-22 Merck & Co., Inc. A method of treating endometriosis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4876259A (en) * 1987-01-05 1989-10-24 E. I. Du Pont De Nemours And Company 3,3-disubstituted indolines
DE69218795T2 (de) * 1992-01-16 1997-07-10 Du Pont Merck Pharma Verbindungen,die neurotransmitter freisetzen,um die lernfähigkeit zu erhöhen
US5595995A (en) * 1992-05-15 1997-01-21 British Technology Group Limited Pyridyl-propan-2-yl esters of 1-adamantane carboxylates
US5258401A (en) * 1992-07-10 1993-11-02 Merck & Co., Inc. Cholesterol lowering compounds
US5912260A (en) * 1994-05-27 1999-06-15 James Black Foundation Limited Gastrin and CCK antagonists
JPH09183725A (ja) * 1995-09-01 1997-07-15 Pfizer Inc ガン治療用治療剤

Also Published As

Publication number Publication date
PT810223E (pt) 2001-12-28
ES2159087T3 (es) 2001-09-16
JPH1045749A (ja) 1998-02-17
DE69705772T2 (de) 2001-11-15
EP0810223B1 (de) 2001-07-25
CA2206104A1 (en) 1997-11-28
EP0810223A1 (de) 1997-12-03
JP3161994B2 (ja) 2001-04-25
DE69705772D1 (de) 2001-08-30
CA2206104C (en) 2000-05-30
DK0810223T3 (da) 2001-09-24
GR3036968T3 (en) 2002-01-31

Similar Documents

Publication Publication Date Title
ATE215954T1 (de) Pyrazolo(4,3-d)pyrimidin-derivate und diese enthaltende pharmazeutische zubereitungen
TR200000059T2 (tr) Piridin türevleri
HU9600834D0 (en) Quinazoline derivatives
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
DE69623899D1 (de) Behandlung von Tinnitus mit neuroprotektiven Wirkstoffen
ATE403430T1 (de) Neue carbamate- und harnstoffderivate als mittel gegen multidrugresistenz
PT977741E (pt) Derivados de fenilo substituido, sua preparacao e utilizacao
ATE339406T1 (de) Chinazoline verbindungen als heilmittel
PT896533E (pt) Pentafluorobenzenosulfonamidas e analogos
DE69630145D1 (de) Taxal derivate, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
DE69716810D1 (de) 2,3-Disubstituierte-(5,6)-heteroarylkondensierte-pyrimidin-4-one
DE60022895D1 (de) Pdgf-rezeptor-kinase hemmende verbindungen, deren herstellung, reinigung und diese verbindungen enthaltende pharmazeutische zusammensetzungen
ATE267187T1 (de) Als entzündungshemmende mittel nützliche dihydrobenzofurane und verwandte verbindungen
ATE193533T1 (de) Taxal derivate, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
DE69703228D1 (de) Neue 6-Hydroxy und 6-Oxo-Androstan Verbindungen mit Kardioaktivität und pharmazeutische Präparate davon
ATE220393T1 (de) Eine heteroethynylen-brücke enthaltende bi- aromatische verbindungen und diese enthaltende pharmazeutische und kosmetische zusammensetzungen
CY1111900T1 (el) Θεραπεια του νευροπαθητικου πονου με ανταγωνιστες υποδοχεα ν-μεθυλ-d-ασπαρτικων (nmda)
DE69612056D1 (de) Terpenderivate (sarcodictyine) als antikrebsmittel
DE69514100D1 (de) Substituierte kondensierte und verbrückte bicyclische verbindungen als therapeutische mittel
ATE181324T1 (de) Im kardiovaskulären system aktive seco-d-steroide und diese enthaltende pharmazeutische zubereitungen
ATE203530T1 (de) Adamantyl substituierte oxindole als pharmazeutische wirkstoffe
FI923662A0 (fi) Terapeutiska medel.
DE59101818D1 (de) Arzneimittelzubereitung, enthaltend Stigmasta-4-en-3-on sowie deren Verwendung.
RU95106652A (ru) Оптически активные производные карбоксамида, аналгезирующее средство
PT889044E (pt) Derivados do 5-(heteroaril)alquil-3-oxo-pirido-(1,2-a)benzimidazole-4-carboxamida (pbi) uteis no tratamento de perturbacoes do sistema nervoso central

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee